Nova Patents
AT369873T

Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain

Abstract

Presently discovered for the GLP-1 of treating acute stroke or cerebral hemorrhage (a vein to medicine) is an ideal method for treatment, comprising the claims a method for optimized insulin secretion, comprising a reinforcing anabolis disease, a through the pressing hand glucagon/glp-1 the insulin the effectiveness, and the normal blood sugar horizontal or hypoglycemia lateral-contraction; and without the serious hypoglycemia's risk.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

64 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
30301699United States of AmericaA

Members64

Family members, oldest first
DocumentOfficeKind
CA2368772A1CanadaA1
CA2372947A1CanadaA1
WO0066138A2World Intellectual Property Organization (WIPO)A2
WO0066142A2World Intellectual Property Organization (WIPO)A2
AU4493500AAustraliaA
AU4682500AAustraliaA
WO0066138A3World Intellectual Property Organization (WIPO)A3
US6284725B1United States of AmericaB1
NO20015294D0NorwayD0
NO20015298D0NorwayD0
NO20015294LNorwayL
NO20015298LNorwayL
EP1173197A2European Patent Office (EPO)A2
WO0066142A3World Intellectual Property Organization (WIPO)A3
EP1187628A2European Patent Office (EPO)A2
MXPA01010859AMexicoA
MXPA01010937AMexicoA
US2002055460A1United States of AmericaA1
CN1349409AChinaA
IL145829D0IsraelD0
IL145830D0IsraelD0
US6429197B1United States of AmericaB1
US2002147131A1United States of AmericaA1
CN1376072AChinaA
JP2002543142AJapanA
JP2002543145AJapanA
HK1046640A1Hong Kong, ChinaA1
US2003073626A1United States of AmericaA1
NZ514610ANew ZealandA
NZ514609ANew ZealandA
AU774084B2AustraliaB2
AU777019B2AustraliaB2
AU2004212547A1AustraliaA1
EP1173197B1European Patent Office (EPO)B1
AT283701TAustriaT
ATE283701T1AustriaT1
DE60016393D1GermanyD1
AU2004240247A1AustraliaA1
EP1512410A1European Patent Office (EPO)A1
DK1173197T3DenmarkT3
PT1173197EPortugalE
ES2233366T3SpainT3
US6982248B2United States of AmericaB2
DE60016393T2GermanyT2
US2006030528A1United States of AmericaA1
EP1187628B1European Patent Office (EPO)B1
US7259136B2United States of AmericaB2
AT369873TThis recordAustriaT
ATE369873T1AustriaT1
DE60035987D1GermanyD1
ES2290029T3SpainT3
AU2004212547B2AustraliaB2
DE60035987T2GermanyT2
NO325601B1NorwayB1
AU2004240247B2AustraliaB2
USRE41288EUnited States of AmericaE
IL145830AIsraelA
US7888314B2United States of AmericaB2
EP1173197B2European Patent Office (EPO)B2
CA2368772CCanadaC
DK1173197T4DenmarkT4
ES2233366T5SpainT5
DE60016393T3GermanyT3
CA2372947CCanadaC